ERBB2 and cancer: In Task 3, which aimed at distinguishing between HER2-zero and HER2-low cancers, LASSO analysis selected 23 radiomic features, comprising 8 from within the tumor and 15 from the peritumoral zone, as illustrated in Figures S2C.